Genelux Corp

GNLX NASDAQ Santé & Biotech États-Unis US36870H1032
2.84 $
2.74 %

Entreprise biopharmaceutique développant des traitements d'immunothérapie contre le cancer à partir de virus oncolytiques.

Performance & Momentum

6 Months 43.87 %
1 Year 8.81 %
3 Years 88.85 %
5 Years 52.75 %

Similar stocks to Genelux Corp

Anantys Community

Be the first to share your analysis on Genelux Corp.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases